Trademark: 97001206
Word
INNERVATE RADIOPHARMACEUTICALS
Status Date
Friday, February 16, 2024
Filing Date
Monday, August 30, 2021
Published for Opposition
Tuesday, February 7, 2023
5 Anticancer pharmaceutical compounds; therapeutic and diagnostic radiopharmaceutical preparations; diagnostic radiopharmaceutical preparations for clinical, medical and research use in the cancer treatments, and cardiovascular treatments; radiopharmaceutical diagnostic preparations for medical use; diagnostic biomarker reagents for medical testing; diagnostic preparations and materials in the nature of diagnostic reagents and diagnostic media for bacteriological culture, for medical purposes; companion diagnostic agents, biomarkers, imaging agents, pet-imaging compounds, all for medical purposes
Feb 17, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 16, 2024
Sou Extension 2 Granted
Feb 16, 2024
Sou Extension 2 Filed
Feb 16, 2024
Sou Teas Extension Received
Sep 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 18, 2023
Sou Extension 1 Granted
Sep 18, 2023
Sou Extension 1 Filed
Sep 18, 2023
Sou Teas Extension Received
Apr 4, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 7, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 7, 2023
Published For Opposition
Jan 18, 2023
Notification Of Notice Of Publication E-Mailed
Jan 5, 2023
Approved For Pub - Principal Register
Dec 29, 2022
Assigned To Examiner
Dec 14, 2022
Teas/Email Correspondence Entered
Dec 13, 2022
Correspondence Received In Law Office
Dec 13, 2022
Teas Response To Office Action Received
Jun 13, 2022
Notification Of Non-Final Action E-Mailed
Jun 13, 2022
Non-Final Action E-Mailed
Jun 13, 2022
Non-Final Action Written
Jun 3, 2022
Assigned To Examiner
Jan 12, 2022
Automatic Update Of Assignment Of Ownership
Oct 13, 2021
New Application Office Supplied Data Entered
Sep 2, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
